Celsius Therapeutics Company
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Total Funding:
148000000.0
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
45200
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Technology:
['BioTech & HealthTech']
Last Funding Date:
2022-03-24
Investors Number:
11.0
Founded Date:
2018-01-01
Industry:
Medical BioTech